Navigation Links
Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
Date:12/1/2009

ors and licensees, including Bayer Schering Pharma, sanofi-aventis, MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2009, filed with the SEC on November 6, 2009, as well as other filings by the company with the SEC.

SOURCE Micromet, Inc.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
2. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
5. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
6. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
7. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
8. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
9. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 20, 2015 Research and Markets( ... "Guide to Prepare Application Dossiers for Oversea ... Edition) " report to their offering. ... of segment market of the most growth potentiality, ... device manufacturers and producers to penetrate such market. ...
(Date:5/22/2015)... , May 22, 2015 Today, ... central nervous system stimulant indicated for the treatment ... patients beginning Summer 2015. The ... received approval from the U.S. Food and Drug ... an extended-release formulation of methylphenidate capsule with an ...
(Date:5/22/2015)... 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... chief executive officer Howie Rosen will be ... officer Tim Morris will be presenting at ... presentations are as follows: Jefferies 2015 Healthcare ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
... , July 26 Perrigo Company (Nasdaq: PRGO ... the U.S. Food and Drug Administration to manufacture and market over-the-counter ... fiscal first quarter 2011. Cherry joins the currently available grape flavor ... store brand flavors. , , ...
... July 26 Halt Medical, Inc. announced today ... appointed to its Scientific Advisory Board.  Dr. Rubin will ... develop and implement comprehensive reimbursement strategies.  Dr. Rubin,s distinguished ... medicine, government, and business. Currently, he is Clinical Professor ...
Cached Medicine Technology:Perrigo Announces FDA Approval for Over-the-Counter Cetirizine Cherry Syrup 2Perrigo Announces FDA Approval for Over-the-Counter Cetirizine Cherry Syrup 3Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor 2
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... May 22, 2015 ZH ... IT solutions, announced today that Bill Lane, joins ... the developer of BlueEHS,a first of its kind, ... a customizable Electronic Health Records (EHR) with an ... a telemedicine-enabled comprehensive patient portal, and more. Combined ...
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... May 22, 2015 Medivo, Inc., a leader ... Rates and Genotype Results in ‘Baby Boomers’ Screened for HCV ... Nationwide Lab Test Database” at Digestive Disease Week, May 16-19, ... Affairs and Analytics team members Carol Smyth, MB; Jason Bhan, ... Parker, MSI, along with Nancy Reau, MD from the University ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... that one particularly aggressive type of blood cancer, mixed lineage ... motors running. The cancer cells rely on the normal version ... happens when a piece of chromosome 11 breaks off at ... another chromosome, resulting in a fusion protein that eventually causes ...
... 2, 2010 Researchers at UT Southwestern Medical Center hope ... against drug dependence. Their hypothesis that increasing the normally ... is based on a rodent study demonstrating that blocking new ... addiction and relapse. The study,s findings, available in the ...
... ... releases Meaningful Use Dashboard for Health Systems. The Meaningful Use Dashboard will provide a ... in regards to Meaningful Use Indicators. , ... Columbus, OH (PRWEB) February 26, 2010 -- Health Care ...
... play key role, study finds , FRIDAY, Feb. 26 (HealthDay ... antibodies may contribute to the development of heart disease in ... is an autoimmune illess in which the immune system creates ... that results in damage to tissue and organs, including the ...
... led to 30 percent reduction in lost tissue, study found ... flow of blood to the heart by repeatedly inflating a ... damaged during a heart attack, a new Danish study shows. ... a hospital for treatment of severe heart attacks, the amount ...
... ... a leading medical informatics company, has signed a strategic partnership agreement with Medical ... easy to deploy diagnostic capability across the healthcare enterprise. , , ... Milwaukee (PRWEB) ...
Cached Medicine News:Health News:Cells of aggressive leukemia hijack normal protein to grow 2Health News:Increasing neurogenesis might prevent drug addiction and relapse 2Health News:HCD Announces Meaningful Use Dashboard for Health Systems 2Health News:New Clues to Lupus' Link With Heart Disease 2Health News:Cutting Off Blood Flow to Heart Limits Damage During Heart Attack 2Health News:Cutting Off Blood Flow to Heart Limits Damage During Heart Attack 3Health News:TeraMedica Inks Reseller Agreement With Medical Insight Enterprise Image Viewer Company 2Health News:TeraMedica Inks Reseller Agreement With Medical Insight Enterprise Image Viewer Company 3
... used to evaluate both low contrast acuity and ... 12.5%) of LogMAR acuity (20/16 to 20/100) are ... the two spatial frequencies of 6 and 12 ... cataract documentation because eye doctors can document cataract ...
... test face is widely used for in or ... presents standard visual acuity from 20/15 to 20/200, ... cycles/degree) and a real-world driver's scene. , ,The ... it provides a standard acuity score, a functional ...
The compact, simple-to-use ECG for medical professionals....
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
Medicine Products: